×
About 2,970 results

ALLMedicine™ Atrial Septal Defect Center

Research & Reviews  1,147 results

The usefulness of 3D printed heart models for medical student education in congenital h...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424617
BMC Medical Education; Karsenty C, Guitarte A et. al.

Sep 10th, 2021 - Three-dimensional (3D) printing technology enables the translation of 2-dimensional (2D) medical imaging into a physical replica of a patient's individual anatomy and may enhance the understanding of congenital heart defects (CHD). We aimed to eva...

Endovascular closure of MINOCA-caused ventricular septal defect (VSD).
https://doi.org/10.1136/bcr-2021-242303
BMJ Case Reports; Petrov IS, Stankov ZI et. al.

Sep 5th, 2021 - Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a rare form of acute myocardial infarction and it is an even rarer cause of ventricular septal defect (VSD). We present a case of successful endovascular closure of post-MINO...

Novel insertion mutation (Arg1822_Glu1823dup) in MYH6 coiled-coil domain causing famili...
https://doi.org/10.1016/j.ejmg.2021.104314
European Journal of Medical Genetics; Huang S, Wu Y et. al.

Sep 5th, 2021 - Atrial septal defect, secundum (ASD Ⅱ, OMIM: 603642) is the second common congenital heart defect (CHD) in China. However, the genetic etiology of familial ASD II remains elusive. Using whole-exome sequencing (WES) and Sanger sequencing, we identi...

Conventional Repair of an Intraoperatively Diagnosed Congenitally Corrected Transpositi...
https://doi.org/10.1532/hsf.3249
The Heart Surgery Forum; Putra MA, Sukardi R et. al.

Sep 3rd, 2021 - Congenitally corrected transposition of the great arteries (ccTGA) is a rare condition that accounts for just 1% of all congenital heart disease. Diagnosis of ccTGA often is missed in adulthood, despite imaging and cardiology consultation. We pres...

Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial ...
https://doi.org/10.1136/heartjnl-2021-319096
Heart (British Cardiac Society); Takaya Y, Akagi T et. al.

Aug 21st, 2021 - Therapeutic strategies for atrial septal defect (ASD) with severe pulmonary arterial hypertension (PAH) are controversial. This study aimed to evaluate the efficacy of PAH-specific medications and subsequent transcatheter closure (ie, treat-and-re...

see more →

News  39 results

Adult Congenital Heart Disease Clinical Practice Guidelines (ESC, 2020)
https://reference.staging.medscape.com/viewarticle/940870

Nov 17th, 2020 - The European Society of Cardiology (ESC) updated their 2010 guidelines on the management of adult congenital heart disease (ACHD) in 2020.[1,2] Class I and III recommendations are outlined. Arrhythmias in ACHD Refer patients with moderate and seve...

Medtronic Recalls Rashkind Balloon Septostomy Catheters
https://www.medscape.com/viewarticle/940354

Nov 4th, 2020 - Medtronic is recalling Rashkind balloon septostomy catheters because of quality problems that may lead to the device breaking, separating, or failing during use, which could cause serious harm, including vascular injury and death, the US Food and ...

Medtronic Recalls Rashkind Balloon Septostomy Catheters for Quality Issues | FDA
https://www.fda.gov/medical-devices/medical-device-recalls/medtronic-recalls-rashkind-balloon-septostomy-catheters-quality-issues

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.   Recalled Product Rashkind Balloon Septostomy Catheter Lot Numbers: See the Recall database entries below ...

No Migraine 'Rebound' Stopping Clopidogrel After ASD Closure 
https://www.medscape.com/viewarticle/938614

Oct 5th, 2020 - Patients being treated with dual-antiplatelet therapy (DAPT) consisting of clopidogrel plus aspirin following atrial septal defect (ASD) closure can safely discontinue clopidogrel after 3 months without fear of increased migraine headaches, a new ...

No Migraine 'Rebound' Stopping Clopidogrel After ASD Closure 
https://www.staging.medscape.com/viewarticle/938614

Oct 5th, 2020 - Patients being treated with dual-antiplatelet therapy (DAPT) consisting of clopidogrel plus aspirin following atrial septal defect (ASD) closure can safely discontinue clopidogrel after 3 months without fear of increased migraine headaches, a new ...

see more →

Patient Education  2 results see all →